NCT05989997View on ClinicalTrials.gov

Phase I Clinical Trial of 68Ga-NOTA-SNA002

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

November 8, 2024

Study Completion Date

November 8, 2024

Conditions
Solid TumorPositron-Emission Tomography(PET)
Interventions
DRUG

68Ga-NOTA-SNA002

68Ga-NOTA-SNA002 should be injected intravenously slowly for no less than 1min.

Trial Locations (1)

Unknown

Zhongshan Hospital Affiliated to Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

SmartNuclide Biopharma

INDUSTRY